Some muscle loss comes with almost any weight loss, and GLP-1 medications like semaglutide and tirzepatide are no exception. In clinical trials, roughly a quarter of the weight people lost was lean tissue, not just fat. The good news: you have real control here. Prioritizing protein, lifting weights a few times a week, titrating your dose sensibly, and not under-eating can protect most of your muscle (and a lot of your face) while the fat comes off.
This matters more for women, and even more in midlife, because women start with less muscle than men and lose it faster after menopause. Here is what the evidence says, and exactly what to do about it.
Key takeaways
- Some lean-mass loss is normal. In tirzepatide's SURMOUNT-1 body-composition sub-study, about 25% of the weight participants lost was lean mass; the rest was fat. Reviews of GLP-1 trials put the lean-mass share at roughly a quarter, sometimes higher with very fast loss.
- Women are more vulnerable. Lower baseline muscle plus age-related muscle loss (sarcopenia) that speeds up around menopause leaves less margin.
- The fix is protective, not restrictive. Eat enough protein (about 0.6-0.8 g per pound of your goal weight), resistance-train 2-3 times a week, don't crash-diet, and lose weight at a steady pace.
- "Ozempic face" is facial-fat loss from rapid weight loss, not a drug-specific side effect. Slower weight loss, protein, hydration, and strength training help.
- Talk to a licensed provider. GLP-1s carry a boxed warning for thyroid C-cell tumors and other cautions; dose and pace should be individualized.
Do semaglutide and tirzepatide cause muscle loss?
They can contribute to it, but the real driver is the weight loss itself, not something unique to the drug. When you lose weight by any method, part of what you shed is fat-free (lean) mass: muscle, connective tissue, and the water they hold. GLP-1 medications work in large part by reducing appetite, so if calories drop sharply and protein and activity don't keep up, your body draws on muscle along with fat.
How much? In the SURMOUNT-1 body-composition sub-study of tirzepatide, published in Diabetes, Obesity and Metabolism in 2025, about 75% of the weight lost was fat mass and 25% was lean mass, and that ratio held steady across age and sex. A 2025 review of GLP-1 and incretin therapies underscores the same worry: because a meaningful share of the weight lost is lean tissue, these medications can raise the concern of sarcopenia (low muscle mass and strength) if nothing is done to counter it, a fraction that can climb higher with faster or larger losses.
Two things put this in perspective. First, losing some lean mass while dropping a lot of fat is expected and not automatically harmful. Second, that same review notes the fraction is not fixed, pairing the medication with resistance exercise and adequate protein is exactly how you shift the ratio toward fat.
Why are women, especially in midlife, more at risk?
Because women have less muscle to spare and lose it faster with age. On average, women carry less lean mass than men to begin with, so the same percentage loss represents a bigger dent in strength and metabolism. Muscle is also metabolically active tissue, losing it can slow the rate at which you burn calories, which can make weight maintenance harder later.
Menopause adds a second hit. As estrogen falls, muscle and bone loss accelerate, a process tied to age-related sarcopenia. That means a woman in perimenopause or after menopause has a smaller buffer than a woman in her 20s or 30s doing the exact same program. It is not a reason to avoid a GLP-1, the medication still works well in midlife, but it is a strong reason to build in muscle protection from day one. (For more on the midlife picture, see our guide to GLP-1s and menopause weight gain.)
What is "Ozempic face," and how do you avoid it?
"Ozempic face" is the gaunt, hollow, or slightly aged look some people notice after fast weight loss, sunken cheeks, under-eye hollowing, and looser skin around the jaw and neck. Despite the nickname, it is not a drug-specific effect. According to the Cleveland Clinic, it happens because rapid weight loss strips subcutaneous fat from the face and can lower collagen and elastin, so the skin has less to support it. It can follow any rapid weight loss, whatever the method.
A quick note on the name: Ozempic is FDA-approved for type 2 diabetes, and its use for weight loss is off-label. Only Wegovy (semaglutide) and Zepbound (tirzepatide) are FDA-approved for chronic weight management. The facial changes people describe aren't tied to any one product.
Cleveland Clinic's prevention advice lines up neatly with muscle protection:
- Lose weight at a steady pace, about one to two pounds a week, so skin and facial tissue can adapt. Your provider can adjust your dose to slow things down.
- Stay hydrated to help skin stay elastic.
- Eat enough protein to build and hold muscle as fat comes off.
- Strength-train to keep the muscle underneath your skin.
In other words, the plan that saves your muscle is largely the same plan that saves your face.
How much protein should you eat on a GLP-1?
Aim for roughly 0.6 to 0.8 grams of protein per pound of your goal (or ideal) body weight per day. For a goal weight of 150 pounds, that's about 90-120 grams of protein daily. This range lines up with the International Society of Sports Nutrition's position stand, which concluded that 1.4-2.0 g/kg of body weight per day supports building and maintaining muscle in active people, and that intakes toward the higher end (up to ~2.3-3.1 g/kg) can help preserve lean mass during a calorie deficit in people who resistance-train.
The catch on a GLP-1 is appetite. When food is less appealing and you fill up fast, protein is the macronutrient most likely to fall short, so make it the deliberate priority at every meal.
| Meal or moment | Protein-first move |
|---|---|
| Breakfast | Eggs, Greek yogurt, cottage cheese, or a protein shake, before coffee or carbs |
| Lunch & dinner | Palm-sized (or larger) portion of lean protein first, then vegetables and starch |
| Snacks | Jerky, edamame, string cheese, a protein bar, or a shake |
| Small appetite | Liquid protein (shakes, milk, high-protein soups) is easier than a big plate |
If you're mapping out meals around the medication's slower digestion, our guide on what to eat on semaglutide pairs well with these protein targets.
How does resistance training protect muscle?
Because muscle responds to demand. When you place a load on a muscle, with dumbbells, machines, resistance bands, or your own body weight, you signal your body to keep and rebuild that tissue even while you're in a calorie deficit. Protein supplies the raw material; training tells your body to use it for muscle rather than let it go.
The evidence is consistent that the two work together, not separately: higher protein without resistance training does far less than the two combined. A practical target is strength training 2 to 3 times a week, hitting the major muscle groups (legs, back, chest, shoulders, arms, core), with a mix that challenges you. Walking and other cardio are great for your heart and overall health, but they don't protect muscle the way lifting does.
You don't need a gym or heavy weights to start. Bodyweight squats, sit-to-stands, wall push-ups, and resistance-band rows count, the point is progressive, regular load.
What else protects muscle (and what about supportive options)?
A few more levers round out the plan:
| Lever | What to aim for | Why it matters |
|---|---|---|
| Pace of weight loss | ~1-2 lb/week; steady, not crash | Faster loss tends to take more lean mass and more facial fat |
| Dose titration | Increase gradually, provider-guided | Sensible titration limits sudden appetite crashes and steep loss |
| Don't under-eat | Enough total calories to fuel training | Severe restriction accelerates muscle loss |
| Sleep & recovery | 7-9 hours where possible | Recovery is when muscle actually adapts and rebuilds |
On the supplement and adjunct front, keep expectations honest. Protein (food or powder) is the workhorse and the most evidence-backed tool here. Some women also ask about sermorelin, a compounded peptide that nudges your own pituitary gland. It is worth being clear: sermorelin is not FDA-approved in its compounded form, is not a weight-loss drug or HGH, and has no approved anti-aging or fat-loss indication. It's sometimes discussed as body-composition and recovery support alongside, never instead of, resistance training and protein. If you're curious, read our honest breakdown of sermorelin for women and treat any peptide as a clinician-decided add-on, not a shortcut.
How Elara helps
Muscle protection isn't a side quest, it belongs in your weight-loss plan from the first dose. Elara's licensed providers review every patient and can set a starting dose and titration pace with your muscle, your goals, and your stage of life in mind, then adjust if weight is coming off too fast. Your plan includes ongoing access to the medical team, plus the Elara app with recipes and workouts to make the protein-and-strength habit realistic.
Explore Elara's semaglutide program for women or compounded tirzepatide, or start with a free eligibility check on our weight-loss program, a licensed provider reviews every patient. Elara's compounded semaglutide starts at $247/month, all-in (medication, provider visit, and shipping included).
Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.
Every GLP-1 also carries a boxed warning for thyroid C-cell tumors and is contraindicated if you or a close relative has had medullary thyroid carcinoma or MEN 2; other cautions include pancreatitis, gallbladder problems, and significant GI effects. GLP-1s are not recommended in pregnancy. Talk to a licensed provider about whether one is right for you.
Frequently asked questions
Does semaglutide cause muscle loss? Some lean-mass loss can happen with the weight loss semaglutide drives, but it's mostly a consequence of losing weight rather than a unique drug effect. In GLP-1 trials, roughly a quarter of the weight lost was lean tissue. Protein, resistance training, and a steady pace of loss protect most of your muscle.
How much muscle do you lose on a GLP-1? It varies, but in tirzepatide's SURMOUNT-1 body-composition sub-study about 25% of the weight lost was lean mass and 75% was fat. That fraction isn't fixed, losing weight faster or eating too little tends to increase muscle loss, while protein and strength training reduce it.
How do you prevent muscle loss on semaglutide or tirzepatide? Eat about 0.6-0.8 g of protein per pound of your goal weight daily, resistance-train two to three times a week, avoid crash dieting, aim for one to two pounds of loss per week, and let your provider titrate the dose gradually. Adequate sleep and total calories help too.
What is "Ozempic face" and how do you avoid it? It's the hollow, aged look that can follow rapid weight loss as the face loses subcutaneous fat and some collagen, not a drug-specific effect. The Cleveland Clinic recommends losing weight slowly, staying hydrated, eating enough protein, and strength training. Naming note: Ozempic is FDA-approved for diabetes; weight loss is off-label.
How much protein should you eat on a GLP-1? A practical target is 0.6-0.8 g per pound of goal body weight, roughly 90-120 g a day for a 150-pound goal. That aligns with sports-nutrition guidance of 1.4-2.0 g/kg, with the higher end favored during active weight loss. Make protein the first thing on your plate, since appetite is lower.
The bottom line
Losing some muscle along with fat is normal on a GLP-1, and women, especially in midlife, have less to spare. But the lever is in your hands: enough protein, regular strength training, a steady pace of weight loss, and a provider-guided dose keep most of your muscle (and much of your face) intact while the fat comes off. Build the plan in from day one, not after the fact.
References
- "The Influence of Glucagon-like Peptide-1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition." PMC / National Library of Medicine, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12733374/
- "Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight." Diabetes, Obesity and Metabolism, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11965027/
- Cleveland Clinic. "'Ozempic Face': What It Is and How to Avoid It." https://health.clevelandclinic.org/ozempic-face
- International Society of Sports Nutrition. "Position Stand: Protein and Exercise." Journal of the International Society of Sports Nutrition, 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5477153/
- U.S. Food and Drug Administration. "Wegovy (semaglutide) injection, Prescribing Information" (boxed warning, thyroid C-cell tumors), Novo Nordisk, via DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
This article is for general education and is not medical advice. Talk to a licensed clinician about your situation.
Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.